Zydus Lifesciences Limited has informed the Exchange about General Updates
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences is acquiring the API (Active Pharmaceutical Ingredients) business of Sterling Biotech Limited (SBL) under a Business Transfer Agreement signed in September 2024. The closing date, originally set for December 31, 2024, was earlier extended to September 30, 2025. SBL is still working on completing certain conditions precedent, so both parties have signed another extension letter pushing the deadline to December 31, 2025. The transaction is now expected to close on or before that date.
The deal is progressing but delayed, which is mildly negative as it signals slow execution; however, both parties remain committed and the extension is procedural, so no material impact on shareholders is expected unless the deal is called off later.